NCT05906147 Health ImprOvement Program of Bone in China
| NCT ID | NCT05906147 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Xiangya Hospital of Central South University |
| Condition | Osteoporosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2021-02-27 |
| Primary Completion | 2021-02-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2021-02-27 with a primary completion date of 2021-02-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fracture risk factors have long been identified as key factors in osteoporosis and fragility fractures. The WHO recommended Fracture risk assessmenttool (FRAX) applies clinical risk factors to assess the absolute risk of osteoporotic fractures in each individual. Our preliminary study suggests that FRAX estimates may underestimate the risk of fractures in the Chinese population. In order to optimize the risk prediction model of osteoporotic fractures, a treatment threshold and its optimal cutting point were initially established based on the data of the health management Center of the Second Xiangya Hospital of Central South University.
Eligibility Criteria
Inclusion Criteria: * Dual-energy X-ray bone mineral density measurement was performed in the health management center of our hospital in the physical examination subjects over 40 years old. Have independent civil capacity and agree to participate, and sign informed consent Exclusion Criteria: * Under 40 years of age， Patients who had undergone hip replacement or lumbar surgery and could not perform dual-energy X-ray BMD testing; Patients who have been treated with effective anti-osteoporosis drugs or have a history of malignant tumors.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05906147 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 100 Years, studying Osteoporosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05906147 currently recruiting?
Yes, NCT05906147 is actively recruiting participants. Contact the research team at shengzhifeng@csu.edu.cn for enrollment information.
Where is the NCT05906147 trial being conducted?
This trial is being conducted at Changsha, China.
Who is sponsoring the NCT05906147 clinical trial?
NCT05906147 is sponsored by Second Xiangya Hospital of Central South University. The trial plans to enroll 5,000 participants.